培门冬酶和左旋门冬酰胺酶治疗儿童急性淋巴细胞白血病的临床分析OACSTPCD
Clinical characterizations of pegaspargase and L-asparaginase in treatment of children with acute lymphoblastic leukemia
目的 探讨培门冬酶(polyethylene glycol conjugated asparaginase,PEG-ASP)和左旋门冬酰胺酶(L-asparaginase,L-ASP)在儿童急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL)中疗效. 方法 回顾性分析第四军医大学西京医院2010-01-01 ～2015-01-01 88例初发的ALL患儿的临床资料,在诱导缓解期随机接受L-ASP治疗42例,PEG…查看全部>>
Objective To explore the efficacy of pegaspargase (PEG-ASP) and L-asparaginase(L-ASP) in children with acute lymphoblastic leukemia(ALL).Methods Clinical data of 88 patients with first-episode ALL were retrospectively analyzed in Xijing Hospital of Fourth Military University from January 2010 to January 2015.Of 88 patients,42 patients were treated with L-ASP,and 46 patients were treated with PEG-ASP during the induction remission period.The clinical efficacy…查看全部>>
张静静;张惠琴;陶小娟;卢星辰;党荣;孙新
第四军医大学西京医院儿科,西安710032第四军医大学西京医院儿科,西安710032第四军医大学西京医院儿科,西安710032第四军医大学西京医院儿科,西安710032第四军医大学西京医院儿科,西安710032第四军医大学西京医院儿科,西安710032
医药卫生
急性淋巴细胞白血病培门冬酶左旋门冬酰胺酶
acute lymphoblastic leukemiapegaspargaseL-asparaginase
《山西医科大学学报》 2017 (5)
485-488,4
评论